TOULOUSE, France--(BUSINESS WIRE)--Regulatory News:
VEXIM (Paris:ALVXM) (FR0011072602 – ALVXM / PEA‐PME), a medical device company specializing in the minimally invasive treatment of vertebral fractures, today announces it has received the regulatory approval from the Therapeutic Goods Administration (TGA) in order to commercialize the SpineJack® and the cement delivery system MasterflowTM in Australia.
This success opens a new market opportunity for VEXIM in Australia which represents a potential market of €30 million in the treatment of vertebral compression fractures according to VEXIM’s estimations.
The company keeps expanding its international presence whilst preparing new products’ development.
Vincent Gardès, VEXIM’s CEO, concludes: “This registration will enable us to have a substantial increase of our global activities. The company considers launching the exportation in Australia by the end of 2016.”
***
About VEXIM, the innovative back microsurgery specialist
Based
in Balma, near Toulouse (France), VEXIM is a medical device company
created in February 2006. The company has specialized in the creation
and marketing of minimally-invasive solutions for treating traumatic
spinal pathologies. Benefitting from the financial support of it
longstanding shareholder, Truffle Capital1 and from BPI
public subsidies, VEXIM has designed and developed the SpineJack®, a
unique implant capable of repairing a fractured vertebra and restoring
the balance of the spinal column. The company also developed the
MasterflowTM, an innovative solution for mixing and injecting
orthopedic cement that enhances the accuracy of the injection and
optimizes the overall surgical procedure. The company counts 62
employees, including its own sales teams in Europe and a network of
international distributors.
VEXIM has been listed on Alternext
Paris since May 2012. For further information, please visit www.vexim.com
SpineJack® 2, a revolutionary implant for
treating Vertebral Fractures
The revolutionary aspect of the
SpineJack® lies in its ability to restore a fractured vertebra to its
original shape, restore the spinal column’s optimal anatomy and thus
remove pain and enable the patient to recover their functional
capabilities. Thanks to a specialized range of instruments, inserting
the implants into the vertebra is carried out by minimally-invasive
surgery, guided by X-ray, in approximately 30 minutes, enabling the
patient to be discharged shortly after surgery. The SpineJack® range
consists of 3 titanium implants with 3 different diameters, thus
covering 95% of vertebral fractures and all patient morphologies.
SpineJack® technology benefits from the support of international
scientific experts in the field of spinal surgery and worldwide patent
protection through to 2029.
MasterflowTM 2, a
high-performance orthopedic cement delivery system
The
MasterflowTM is an innovative solution for mixing and
injecting orthopedic cement that enhances the accuracy of the injection
and optimizes the overall surgical procedure for treating vertebral
compression fractures. The device provides a better control of the
injection of biomaterials into the spine. A complement of the
SpineJack®, the MasterflowTM stands out for being both easy
to use and precise, particularly in its ability to stop the cement
delivery instantly without inertia. The MasterflowTM
contributes to reducing pain in patients. Its first sales were recorded
in the U.S. in February 2015, and the system has also received the CE
marking in February 2015, a mandatory conformity mark for products
marketed in Europe.
1 Founded in 2001 in Paris, Truffle Capital is a leading independent European private equity firm. It is dedicated to investing in and building technology leaders in the IT, life sciences and energy sectors. Truffle Capital manages €550m via FCPRs and FCPIs, the latter offering tax rebates (funds are blocked during 7 to 10 years). For further information, please visit www.truffle.fr and www.fcpi.fr.
2 This medical device is a regulated health product that, with regard to these regulations, bears the CE mark. Please refer to the Instructions for Use.
